Atlas Venture Life Science Advisors, LLC - AKERO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Atlas Venture Life Science Advisors, LLC ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$18,170,915
-34.5%
359,251
-39.5%
2.81%
-18.5%
Q2 2023$27,745,579
+22.0%
594,2510.0%3.45%
+12.2%
Q1 2023$22,736,043
-30.2%
594,2510.0%3.08%
-21.5%
Q4 2022$32,564,955
-3.8%
594,251
-40.2%
3.92%
+5.0%
Q3 2022$33,854,000
+60.5%
994,251
-55.5%
3.74%
+5.9%
Q2 2022$21,095,000
-33.4%
2,232,2510.0%3.53%
-11.9%
Q1 2022$31,676,000
-32.9%
2,232,2510.0%4.00%
-7.6%
Q4 2021$47,212,0002,232,2514.34%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
University of Wisconsin Foundation 103,816$5,251,0136.02%
Boxer Capital, LLC 1,676,733$84,809,1554.52%
Redmile Group, LLC 1,769,684$89,510,6174.26%
Ghost Tree Capital, LLC 250,000$12,645,0004.16%
Logos Global Management LP 600,000$30,348,0004.05%
COMMODORE CAPITAL LP 565,000$28,577,7003.34%
Yiheng Capital Management, L.P. 1,221,674$61,792,2713.15%
SILVERARC CAPITAL MANAGEMENT, LLC 200,000$10,116,0003.07%
Atlas Venture Life Science Advisors, LLC 359,251$18,170,9152.81%
Perceptive Advisors 1,619,425$81,910,5172.73%
View complete list of AKERO THERAPEUTICS INC shareholders